Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

High-blood pressure medication voluntarily recalled: FDA

Summary
A New Jersey drug maker has voluntarily recalled thousands of bottles of a combination high blood pressure medication over concerns the product could be cross-contaminated with another drug, the Federal Drug Administration said. The recall covers more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets under the brand name Ziac. Testing of reserve samples showed presence of ezetimibe, a drug used for high cholesterol, FDA officials said in a report published online.

15 Articles

USA TodayUSA Today
Lean Left

Blood pressure drug possible cross-contamination recalled by NJ company

The maker of the hypertension medication Ziac, based in Elmwood Park, is recalling the drug for possible cross-contamination with a cholesterol drug.

·United States
Read Full Article
The HillThe Hill
+13 Reposted by 13 other sources
Center

High-blood pressure medication voluntarily recalled: FDA

Glenmark Pharmaceuticals Inc. in Elmwood Park, N.J., is recalling the pills, which are in 2.5 mg and 6.25 mg doses.

·Washington, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 93% of the sources are Center
93% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PHL17 broke the news in on Saturday, December 6, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

FDA icon

FDA

Medical icon

Medical

Health icon

Health

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal